Overview

Study of the Nasal Decolonisation of Staphylococcus Aureus (SA) and the Safety and Tolerability of XF-73 Nasal Gel in Healthy Subjects

Status:
Completed

Trial end date:
2014-11-01

Target enrollment:

Participant gender:

Summary

Study to determine the efficacy, safety and tolerability of two concentrations of XF-73 nasal gel in combination with body and face washing with chlorhexidine gluconate cloths in eradicating nasal carriage of Staphylococcus aureus.

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Destiny Pharma Ltd
Destiny Pharma Plc

Treatments:

Chlorhexidine
Chlorhexidine gluconate